Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-23

Clinical Trial Update: Enteric-Coated Peppermint Oil Versus Standard Antispasmodic in SLC6A4 (5-HTTLPR) Carriers With Irritable Bowel Syndrome. [NA]

View source ↗

Summary

A completed clinical trial comparing enteric-coated peppermint oil to a standard antispasmodic in irritable bowel syndrome patients who carry the SLC6A4 (5-HTTL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enteric-coated peppermint oil (mentha piperita oil (peppermint oil))
  • Standard antispasmodic

Snippet

Sponsor: S.LAB (SOLOWAYS) | Conditions: Irritable Bowel Syndrome (IBS) | NA | Status: COMPLETED